CDK4 Specific Recomb™ Antibody (V3S-1123-CJ3), Human IgG (CAT#: V3S-1123-CJ3)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This recombinant human antibody (clone AK2) is against human cyclin-dependent kinase 4 (CDK4). AK2 could specifically recognize and interacted with recombinant human CDK4 and endogenous CDK4 in tumor cells by WB, IF and Co-IP.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; IF; WB; Co-IP
Application Notes The binding affinity of the mAb with CDK4 was determinated by noncompetitive ELISA (1 μg/mL, 2 μg/mL, 4 μg/mL, 8 μg/mL). The antibody is recommended for detection of CDK4 by Immunofluorescence assay, Western Blot and Co-immunoprecipitation assays in HeLa and MCF-7 cells.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CDK4
Alternative Name CMM3; PSK-J3; Cyclin dependent kinase 4
Gene ID 1019
UniProt P11802
Research Area Cell Biology; Epigenetics
Related Disease Tumors
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry